HRSA-23-025: FY 2023 Ending the HIV Epidemic - Primary Care HIV Prevention
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2022.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 140 awards worth $50.0 million in total. Applications closed on January 17, 2023.
From the official notice on Grants.gov, last changed November 15, 2022. Checked November 7, 2026.
- Total funding$50.0 million
- Expected awards140
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| HRSA-22-104 | October 7, 2021 | Closed December 14, 2021 | Closed |
Key dates
| Posted | November 15, 2022 |
|---|---|
| Deadline | January 17, 2023 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Organizations that currently receive an H80 grant award, are located in the 57 geographic locations identified by Ending the HIV Epidemic in the US, and did not receive an FY 2020, FY 2021, or FY 2022 PCHP award.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
PCHP funding will expand HIV prevention services that decrease the risk of HIV transmission in underserved communities in support of Ending the HIV Epidemic in the U.S. This FY 2023 funding opportunity will make available HIV prevention investments to Health Center Program operational (H80) award recipients located in Ending the HIV Epidemic in the U.S. geographic locations that did not receive FY 2020, FY 2021, or FY 2022 PCHP funding.
Who has won Grants for New and Expanded Services under the Health Center Program grants before
From fiscal 2021 to 2025, Grants for New and Expanded Services under the Health Center Program (93.527) awarded $12 billion across 4,298 grant awards, an average of $2.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Clinica Sierra Vista | California | 3 | $57.7 million |
| Sun River Health, Inc. | New York | 4 | $56.5 million |
| Yakima Valley Farm Workers Clinic | Washington | 3 | $48.6 million |
| Quality of Life Health Services, Inc. | Alabama | 3 | $40.4 million |
| Family Healthcare Network | California | 2 | $39.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-23-025 still open?
No. It closed on January 17, 2023.
Who can apply for FY 2023 Ending the HIV Epidemic - Primary Care HIV Prevention?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for FY 2023 Ending the HIV Epidemic - Primary Care HIV Prevention?
Closed January 17, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $50.0 million in total across about 140 awards.
Who has won Grants for New and Expanded Services under the Health Center Program grants before?
The largest recipients over five fiscal years were Clinica Sierra Vista, Sun River Health, Inc., Yakima Valley Farm Workers Clinic. The program made 4,298 awards worth $12 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)